Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

407 ARTÍCULOS , VIENDO DEL 151 AL 165

De Novo DNM1L Variant in a Teenager With Progressive Paroxysmal Dystonia and Lethal Super-refractory Myoclonic Status Epilepticus

Ryan CS, Fine AL, Cohen AL, Schiltz BM, Renaud DL, Wirrell EC, Patterson MC, Boczek NJ, Liu R, Babovic-Vuksanovic D, Chan DC, Payne ET.

J Child Neurol. 2018 Sep;33(10):651-658. doi: 10.1177/0883073818778203. Epub 2018 Jun 7.

Movement disorders in non-encephalopathic Hashimoto's thyroiditis

Miranda M, Bustamante ML, Campero M, Wainstein E, Toche P, Espay AJ, Walker RH, Lang AE.

Parkinsonism Relat Disord. 2018 Oct;55:141-142. doi: 10.1016/j.parkreldis.2018.06.008. Epub 2018 Jun 5.

Both Deep Brain Stimulation and Thalamotomy in a 13-Year-Old Patient with Primary Dystonia

Lin H, Cai XD, Zhang DD, Liu JL, Li WP.

World Neurosurg. 2018 Sep;117:68-73. doi: 10.1016/j.wneu.2018.05.248. Epub 2018 Jun 8.

The cerebellum and dystonia

Bologna M, Berardelli A.

Handb Clin Neurol. 2018;155:259-272. doi: 10.1016/B978-0-444-64189-2.00017-2.

[A rare early-onset dystonia (DYT16) in a Portuguese girl]

Almeida S, Rangel MA, Neiva C, Carrilho I, Leao M, Santos F, Vila Real M.

Rev Neurol. 2018 Jun 16;66(12):434.

Long-Term Effect of GPi-DBS in a Patient With Generalized Dystonia Due to GLUT1 Deficiency Syndrome

Hanci I, Kamm C, Scholten M, Roncoroni LP, Weber Y, Krüger R, Plewnia C, Gharabaghi A, Weiss D.

Front Neurol. 2018 May 30;9:381. doi: 10.3389/fneur.2018.00381. eCollection 2018.

Aicardi-Goutières Syndrome: Brief Case Report

Moscote-Salazar LR, Calderon-Miranda WG, Deluquez Baute RV, Agrawal A, Satyarthee GD, Maraby-Salgado J, Padilla-Zambrano HS, Lopez-Cepeda D, Pacheco-Hernandez A, Joaquim AF.

J Pediatr Neurosci. 2018 Jan-Mar;13(1):88-90. doi: 10.4103/JPN.JPN_67_17.

Neuropsychological Difficulties Associated with Dopa Responsive Dystonia

Baskaran D, Khan A, Hussain N.

J Pediatr Neurosci. 2018 Jan-Mar;13(1):100-102. doi: 10.4103/JPN.JPN_142_17.

ATP13A2 novel mutations causing a rare form of juvenile-onset Parkinson disease

Suleiman J, Hamwi N, El-Hattab AW.

Brain Dev. 2018 Oct;40(9):824-826. doi: 10.1016/j.braindev.2018.05.017. Epub 2018 Jun 11.

Short-term efficacy and tolerability of lurasidone in the treatment of acute schizophrenia: A meta-analysis of randomized controlled trials

Zheng W, Cai DB, Yang XH, Li L, Zhang QE, Ng CH, Ungvari GS, Li XB, Ning YP, Xiang YT.

J Psychiatr Res. 2018 Aug;103:244-251. doi: 10.1016/j.jpsychires.2018.06.005. Epub 2018 Jun 5.

Adverse events with botulinum toxin treatment in cervical dystonia: How much should we blame placebo?

Duarte GS, Rodrigues FB, Ferreira JJ, Costa J.

Parkinsonism Relat Disord. 2018 Nov;56:16-19. doi: 10.1016/j.parkreldis.2018.06.017. Epub 2018 Jun 15.

Low Voice, Spasmodic Dysphonia, and Hand Dystonia as Clinical Clues for KMT2B-Associated Early-Onset Dystonia

Hackenberg A, Wagner M, Pahnke J, Zeitler P, Boltshauser E.

Neuropediatrics. 2018 Oct;49(5):356. doi: 10.1055/s-0038-1661343. Epub 2018 Jun 18.

Aripiprazole in a Patient of PLA2G6-Associated Neurodegeneration With Psychosis

Huang MH, Chiu YC, Tsai CF.

Clin Neuropharmacol. 2018 Jul/Aug;41(4):136-137. doi: 10.1097/WNF.0000000000000284.

De novo ATP1A3 and compound heterozygous NLRP3 mutations in a child with autism spectrum disorder, episodic fatigue and somnolence, and muckle-wells syndrome

Torres A, Brownstein CA, Tembulkar SK, Graber K, Genetti C, Kleiman RJ, Sweadner KJ, Mavros C, Liu KX, Smedemark-Margulies N, Maski K, Yang E, Agrawal PB, Shi J, Beggs AH, D'Angelo E, Lincoln SH, Carroll D, Dedeoglu F, Gahl WA, Biggs CM, Swoboda KJ, Berry GT, Gonzalez-Heydrich J.

Mol Genet Metab Rep. 2018 Jun 15;16:23-29. doi: 10.1016/j.ymgmr.2018.06.001. eCollection 2018 Sep.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias